Friday, May 22, 2009

Drug Companies’ Overseas Operations Cause Tax Headaches

GlaxoSmithKline is in another dispute with the IRS after paying some $3.4 billion to end litigation a few years ago.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)